$PCMC
PUBLIC CO MANAGEMENT CORP

2024 Q3 Form 10-Q Financial Statement

#000121465924014147 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.32K
YoY Change 770.77%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.32K
YoY Change 771.44%
Operating Profit -$11.32K
YoY Change 771.44%
Interest Expense $2.625K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net -$2.625K
YoY Change 0.0%
Pretax Income -$13.95K
YoY Change 255.87%
Income Tax
% Of Pretax Income
Net Earnings -$13.95K
YoY Change 255.38%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 34.28M shares 34.28M shares
Diluted Shares Outstanding 34.28M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.75K
YoY Change 1181.09%
Cash & Equivalents $25.75K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.75K
YoY Change 1181.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$5.00
YoY Change -266.67%
TOTAL ASSETS
Total Short-Term Assets $25.75K
Total Long-Term Assets -$5.00
Total Assets $25.75K
YoY Change 1178.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.75K
YoY Change 1.18%
Accrued Expenses $81.40K
YoY Change 14.81%
Deferred Revenue
YoY Change
Short-Term Debt $425.0K
YoY Change 21.43%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $567.2K
YoY Change 17.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $567.2K
Total Long-Term Liabilities $0.00
Total Liabilities $567.2K
YoY Change 17.93%
SHAREHOLDERS EQUITY
Retained Earnings -$5.595M
YoY Change 1.13%
Common Stock $34.28K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$541.4K
YoY Change
Total Liabilities & Shareholders Equity $25.75K
YoY Change 1178.94%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$13.95K
YoY Change 255.38%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.820K
YoY Change 19540.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -9.820K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -9.820K
YoY Change 19540.0%
FREE CASH FLOW
Cash From Operating Activities -$9.820K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Revenues
Revenues
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001141964
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50098
dei Entity Registrant Name
EntityRegistrantName
PUBLIC CO MANAGEMENT CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0493734
dei Entity Address City Or Town
EntityAddressCityOrTown
Beverly Hills
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90212
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Operating Expenses
OperatingExpenses
36711 usd
us-gaap Operating Expenses
OperatingExpenses
10037 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-36711 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10037 usd
us-gaap Interest Expense
InterestExpense
7875 usd
us-gaap Interest Expense
InterestExpense
7875 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7875 usd
CY2023Q3 PCMC Related Party Accrued Liabilities
RelatedPartyAccruedLiabilities
45232 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Depreciation
Depreciation
0 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
70904 usd
CY2023Q3 PCMC Due To Related Party
DueToRelatedParty
45232 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34276816 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
PCMC Accounts Payables And Accrued Expenses Related Party
AccountsPayablesAndAccruedExpensesRelatedParty
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Entity Address Address Line1
EntityAddressAddressLine1
9340 Wilshire Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 203
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
862.1957
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
PCMC
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34276816 shares
CY2024Q2 us-gaap Cash
Cash
25745 usd
CY2023Q3 us-gaap Cash
Cash
58766 usd
CY2024Q2 us-gaap Assets
Assets
25745 usd
CY2023Q3 us-gaap Assets
Assets
58766 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15522 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11832 usd
CY2024Q2 PCMC Accounts Payable And Accrued Expenses Related Party
AccountsPayableAndAccruedExpensesRelatedParty
45232 usd
CY2023Q3 PCMC Accounts Payable And Accrued Expenses Related Party
AccountsPayableAndAccruedExpensesRelatedParty
45232 usd
CY2024Q2 PCMC Shortterm Payables
ShorttermPayables
75000 usd
CY2023Q3 PCMC Shortterm Payables
ShorttermPayables
75000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
81404 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
73529 usd
CY2024Q2 PCMC Note Payable Related Party
NotePayableRelatedParty
350000 usd
CY2023Q3 PCMC Note Payable Related Party
NotePayableRelatedParty
350000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
567158 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
555593 usd
CY2024Q2 us-gaap Liabilities
Liabilities
567158 usd
CY2023Q3 us-gaap Liabilities
Liabilities
555593 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34276816 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34276816 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34276816 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34276816 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
34277 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
34277 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5019739 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5019739 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5595429 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5550843 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-541413 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-496827 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25745 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58766 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11320 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1299 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36711 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10037 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
11320 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1299 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11320 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1299 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
2625 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2625 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2625 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2625 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7875 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13945 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3924 usd
us-gaap Net Income Loss
NetIncomeLoss
-44586 usd
us-gaap Net Income Loss
NetIncomeLoss
-17912 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34276816 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34276816 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34276816 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34276816 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34276816 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34276816 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34276816 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34276816 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-527468 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-13945 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-541413 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-475007 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3924 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-478931 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-496827 usd
us-gaap Profit Loss
ProfitLoss
-44586 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-541413 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-461019 usd
us-gaap Profit Loss
ProfitLoss
-17912 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-478931 usd
us-gaap Profit Loss
ProfitLoss
-44586 usd
us-gaap Profit Loss
ProfitLoss
-17912 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3690 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5466 usd
PCMC Accounts Payables And Accrued Expenses Related Party
AccountsPayablesAndAccruedExpensesRelatedParty
13068 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7875 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7875 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33021 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2435 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-33021 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2435 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58766 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4448 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25745 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2013 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_848_eus-gaap--NatureOfOperations_zxZ0csbFs7ag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_868_zX3WHqtYkiR6">Nature of Business</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">Public Company Management Corporation ("Company”), a Nevada corporation, was formed on October 26, 2000. On October 1, 2004, MyOffiz, Inc. ("MyOffiz") entered into an Exchange Agreement with the certain controlling shareholders of GoPublicToday.com, Inc., Pubco WhitePapers, Inc., and Public Company Management Services, Inc. The Company was the holding company for, and conducted its operations through, its subsidiary companies. The terms "we" and "our" refers to the Company and its subsidiaries unless otherwise stated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">Pursuant to the Exchange Agreement, MyOffiz acquired approximately <span id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_c20240630__us-gaap--BusinessAcquisitionAxis__custom--MyOffizMember_pdd" title="Percentage acquired">92.1%</span> of the outstanding shares of GoPublicToday.com, Inc., all of the outstanding shares of Pubco WhitePapers, Inc., and all of the outstanding shares of Public Company Management Services, Inc in exchange for the new issuance of an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231001__20240630__srt--CounterpartyNameAxis__custom--MyOffizMember_pdd" title="Number of common stock issued during the period">15,326,650</span> of MyOffiz's common stock. Subsequent to the Exchange Agreement, MyOffiz obtained 100% of the partially owned subsidiaries, changed its fiscal year end from June 30 to September 30, and changed its name to Public Company Management Corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">The Company was a management consulting firm that educated and assisted small businesses to improve their management, corporate governance, regulatory compliance, and other business processes, with a focus on capital market participation. The Company offered the following services to its clients at various stages of the business lifecycle:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 50px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Educational products to improve business processes or explore entering the capital markets;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 50px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Startup consulting to early-stage companies planning for growth;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 50px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management consulting to companies seeking to enter the capital markets via self-underwriting or direct public offering or to move from one capital market to another; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 50px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance services to fully reporting, publicly traded companies.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.5in; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">The Company generated revenues primarily from consulting services that it provided to private company clients seeking to become fully reporting, publicly traded companies. The Company also generated revenue from regulatory compliance services that the Company was providing to public company clients that are required to file periodic and other reports with the Securities and Exchange Commission (“SEC”). The Company would be paid a flat fee for these services, which generally consisted of cash and restricted shares of the Company’s clients’ common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">Predicated upon the economic recession of 2008, commencing with the subprime mortgage crisis and bank crisis, a significant increase in housing foreclosures ultimately caused the stock market to crash in September 2008. At that time, and prior, the Company faced competition from a large number of consulting firms, investment banks, venture capitalists, merchant banks, financial advisors, and other similar management consulting and regulatory compliance services firms. Due to (i) the inability to raise funds in the marketplace and (ii) the intense competition in every aspect of the Company’s business, the Company was unable to operate profitably.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zCDLV9WUZ6Ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86E_zMDm933MyDLj">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions by management in determining the reported amounts of assets and liabilities, disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are primarily used in our revenue recognition, long-lived asset impairments and adjustments, deferred tax, stock-based compensation, and reserves for legal matters. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44586 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17912 usd
us-gaap Net Income Loss
NetIncomeLoss
-44586 usd
us-gaap Net Income Loss
NetIncomeLoss
-17912 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34276816 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34276816 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34276816 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34276816 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
PCMC Related Party Transactions Policytext Block
RelatedPartyTransactionsPolicytextBlock
<p id="xdx_847_ecustom--RelatedPartyTransactionsPolicytextBlock_zvh72CXDJjm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><b><span id="xdx_86A_z4zdUY0sRrt6">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">The Company follows ASC 850, <i>Related Party Disclosures</i>, for the identification of related parties and disclosure of related party transactions. Related party note and interest balances as of June 30, 2024 and September 30, 2023 were $<span id="xdx_906_ecustom--RelatedPartyNoteAndInterestBalances_c20240630_pp0p0" title="Related party note and interest balances">431,404</span> and $<span id="xdx_908_ecustom--RelatedPartyNoteAndInterestBalances_c20230930_pp0p0" title="Related party note and interest balances">423,529</span>, respectively and related party accrued liabilities as of June 30, 2024 and September 30, 2023 of $<span id="xdx_905_ecustom--RelatedPartyAccruedLiabilities_c20240630_pp0p0" title="Related party accrued liabilities">45,232</span> and $<span id="xdx_907_ecustom--RelatedPartyAccruedLiabilities_c20230930_pp0p0" title="Related party accrued liabilities">45,232</span>, respectively (see Note 4. Related Party Transactions).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q2 PCMC Related Party Note And Interest Balances
RelatedPartyNoteAndInterestBalances
431404 usd
CY2023Q3 PCMC Related Party Note And Interest Balances
RelatedPartyNoteAndInterestBalances
423529 usd
CY2024Q2 PCMC Related Party Accrued Liabilities
RelatedPartyAccruedLiabilities
45232 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Depreciation
Depreciation
0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5595429 usd
CY2024Q2 PCMC Working Capital Deficit
WorkingCapitalDeficit
541413 usd
CY2024Q2 PCMC Shortterm Payables
ShorttermPayables
75000 usd
us-gaap Interest Expense
InterestExpense
7875 usd
us-gaap Interest Expense
InterestExpense
7875 usd
CY2024Q2 PCMC Note Payable Related Party
NotePayableRelatedParty
350000 usd
CY2023Q3 PCMC Note Payable Related Party
NotePayableRelatedParty
350000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
81404 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
73529 usd
CY2024Q2 PCMC Note Payable Related Party
NotePayableRelatedParty
350000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
81404 usd
CY2024Q2 PCMC Due To Related Party
DueToRelatedParty
45232 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34276816 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2024Q2 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
5595429 usd
CY2023Q3 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
5550843 usd
PCMC Offset Income
OffsetIncome
139237 usd

Files In Submission

Name View Source Status
0001214659-24-014147-index-headers.html Edgar Link pending
0001214659-24-014147-index.html Edgar Link pending
0001214659-24-014147.txt Edgar Link pending
0001214659-24-014147-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcmc-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
z8524410q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pcmc-20240630_cal.xml Edgar Link unprocessable
pcmc-20240630_def.xml Edgar Link unprocessable
pcmc-20240630_lab.xml Edgar Link unprocessable
pcmc-20240630_pre.xml Edgar Link unprocessable
z8524410q_htm.xml Edgar Link completed